肥胖与类风湿关节炎临床缓解率及低MRI炎症的关系
本研究基于GO-BEFORE和GO-FORWARD两项随机临床试验的470例类风湿关节炎患者,评估肥胖对实现临床和影像学低疾病活动度的影响。结果显示,肥胖患者24周时达到DAS28-CRP缓解的几率显著更低(OR 0.47),但低滑膜炎、低炎症评分及低骨炎评分的几率与正常体重患者相似或更高,提示肥胖可能偏倚临床疾病活动度评估。
要点
- 肥胖RA患者24周DAS28-CRP缓解率显著低于非肥胖者(OR 0.47)。
- 肥胖与低MRI滑膜炎、低总炎症评分无显著关联。
- 肥胖患者低MRI骨炎评分几率反而更高(OR 2.06)。
核心结论
- 肥胖RA患者DAS28缓解率较低,但MRI低活动度率与正常体重者相似,提示临床评估可能受肥胖偏倚。
研究设计与样本
- 研究纳入GO-BEFORE和GO-FORWARD随机临床试验中的470例RA患者,基线、24周和52周进行盲法临床疾病活动度评估和MRI检查。
- 采用RA MRI评分系统评估滑膜炎、骨炎和总炎症评分,并用多变量logistic回归比较肥胖与非肥胖患者24周时达到缓解或低活动度的比值比。
主要发现
- 24周时,肥胖患者达到DAS28-CRP缓解的比值比显著低于非肥胖患者(OR 0.47;95%CI 0.24-0.92,p=0.03)。
- 肥胖患者达到低滑膜炎评分的比值比与非肥胖者相似(OR 0.94;95%CI 0.51-1.72,p=0.84)。
- 肥胖患者达到低总炎症评分的比值比与非肥胖者相似(OR 1.16;95%CI 0.61-2.22,p=0.64)。
- 肥胖患者达到低骨炎评分的比值比高于正常体重患者(OR 2.06;95%CI 1.10-3.84,p=0.02)。
关键数值与推荐
- DAS28-CRP缓解定义基于28关节疾病活动度评分和C反应蛋白。
- 低MRI炎症定义基于RA MRI评分系统的滑膜炎、骨炎和总炎症评分。
临床怎么用
- 对于肥胖RA患者,临床疾病活动度评分如DAS28可能高估疾病活动,应结合影像学评估。
- 肥胖患者临床缓解率较低不一定反映真实炎症控制不佳,需谨慎解读临床指标。
局限性
- 研究为对随机临床试验数据的二次分析,肥胖定义及MRI评估细节未在摘要中详述。
- 样本来自特定临床试验人群,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Obesity has been proposed as a risk factor for refractory rheumatoid arthritis (RA). We evaluated the impact of obesity on achieving clinical and imaging definitions of low disease activity. METHODS: This study evaluated 470 patients with RA from GO-BEFORE and GO-FORWARD randomised clinical trials. Included patients had blinded clinical disease activity measures and MRI at baseline, 24 and 52 weeks. Synovitis, osteitis and total inflammation scores were determined using the RA MRI scoring system. Multivariable logistic regression analyses compared odds of achieving Disease Activity Score using 28 joints and C-reactive protein (DAS28-CRP) remission, low component measures, or low MRI inflammation measures at 24 weeks in patients with obesity versus no obesity. RESULTS: At 24 weeks, patients with obesity were significantly less likely to achieve DAS28(CRP) remission (OR 0.47; 95% CI 0.24 to 0.92, p=0.03). In contrast, patients with obesity had similar odds of achieving low synovitis (OR 0.94; 95% CI 0.51 to 1.72, p=0.84) and inflammation scores (OR 1.16; 95% CI 0.61 to 2.22, p=0.64) and greater odds of achieving low osteitis scores (OR 2.06; 95% CI 1.10 to 3.84, p=0.02) versus normal weight patients. CONCLUSIONS: Patients with RA and obesity have lower rates of DAS28 remission but similar rates of low MRI activity compared with patients without obesity, suggesting that obesity and its associated comorbidities can bias clinical disease activity measures. TRIAL REGISTRATION NUMBER: NCT00361335 and NCT00264550; Post-results.
引用
- George MD, Østergaard M, Conaghan PG, et al. Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis. Ann Rheum Dis. 2017. PMID: 28606966. doi:10.1136/annrheumdis-2017-211569
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。